Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia vera

被引：70

作者：

Tefferi, A. ^{[1
]}

Strand, J. J.

Lasho, T. L.

Knudson, R. A.

Finke, C. M.

Gangat, N.

Pardanani, A.

Hanson, C. A.

Ketterling, R. P.

机构：

[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA

[2] Mayo Clin, Lab Cytogenet, Rochester, MN USA

[3] Mayo Clin, Lab Hematopathol, Rochester, MN USA

来源：

LEUKEMIA | 2007年 / 21卷 / 09期

关键词：

D O I：

10.1038/sj.leu.2404724

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2074 / 2075

页数：3

共 7 条

[1] Long-term serial analysis of X-chromosome inactivation patterns and JAK2 V617F mutant levels in patients with essential thrombocythemia show that minor mutant-positive clones can remain stable for many years [J].

Gale, Rosemary E. ;

Allen, Anthony J. R. ;

Nash, Michael J. ;

Linch, David C. .

BLOOD, 2007, 109 (03) :1241-1243

[2] Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients [J].

Gangat, N. ;

Wolanskyj, A. P. ;

McClure, R. F. ;

Li, C-Y ;

Schwager, S. ;

Wu, W. ;

Tefferi, A. .

LEUKEMIA, 2007, 21 (02) :270-276

[3]

KITTUR J, 2007, IN PRESS CANCER

[4] X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and NIMM patients with clonal hematopoiesis [J].

Levine, Ross L. ;

Belisle, Claude ;

Wadleigh, Martha ;

Zahrieh, David ;

Lee, Stephanie ;

Chagnon, Pierre ;

Gilliland, D. Gary ;

Busque, Lambert .

BLOOD, 2006, 107 (10) :4139-4141

[5] JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis [J].

Scott, Linda M. ;

Tong, Wei ;

Levine, Ross L. ;

Scott, Mike A. ;

Beer, Philip A. ;

Stratton, Michael R. ;

Futreal, P. Andrew ;

Erber, Wendy N. ;

McMullin, Mary Frances ;

Harrison, Claire N. ;

Warren, Alan J. ;

Gilliland, D. Gary ;

Lodish, Harvey F. ;

Green, Anthony R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (05) :459-468

[6] The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera [J].

Tefferi, A ;

Lasho, TL ;

Schwager, SM ;

Strand, JS ;

Elliott, M ;

Mesa, R ;

Li, CY ;

Wadleigh, M ;

Lee, SJ ;

Gilliland, DG .

CANCER, 2006, 106 (03) :631-635

[7] A quantitative assay for JAK2V617F mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis [J].

Vannucchi, A. M. ;

Pancrazzi, A. ;

Bogani, C. ;

Antonioli, E. ;

Guglielmelli, P. .

LEUKEMIA, 2006, 20 (06) :1055-1060

← 1 →